Roy R. Teller

Array ( [id] => 5953900 [patent_doc_number] => 20110034399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'Liquid and Freeze Dried Formulations' [patent_app_type] => utility [patent_app_number] => 12/936349 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4724 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034399.pdf [firstpage_image] =>[orig_patent_app_number] => 12936349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10514980 [patent_doc_number] => 09242011 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-26 [patent_title] => 'Insulin albumin conjugates' [patent_app_type] => utility [patent_app_number] => 12/935438 [patent_app_country] => US [patent_app_date] => 2009-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 15081 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 430 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12935438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7683656 [patent_doc_number] => 20100240755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'THERAPEUTIC AND COSMETIC COMPOSITIONS FOR TREATMENT OF SKIN' [patent_app_type] => utility [patent_app_number] => 12/408341 [patent_app_country] => US [patent_app_date] => 2009-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1086 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20100240755.pdf [firstpage_image] =>[orig_patent_app_number] => 12408341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5403474 [patent_doc_number] => 20090238788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'DELIVERY OF HYDROGELS AS SPRAYS' [patent_app_type] => utility [patent_app_number] => 12/407079 [patent_app_country] => US [patent_app_date] => 2009-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3427 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20090238788.pdf [firstpage_image] =>[orig_patent_app_number] => 12407079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5945102 [patent_doc_number] => 20110105722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'Peptide synthesis method using n-carboxyanhydride (UNCA)' [patent_app_type] => utility [patent_app_number] => 12/921413 [patent_app_country] => US [patent_app_date] => 2009-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3056 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105722.pdf [firstpage_image] =>[orig_patent_app_number] => 12921413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8664405 [patent_doc_number] => 08377866 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-19 [patent_title] => 'Antimicrobial protein derived from Podoviridae bacteriophage specific to Staphylococcus aureus' [patent_app_type] => utility [patent_app_number] => 12/378365 [patent_app_country] => US [patent_app_date] => 2009-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 7474 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12378365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6468523 [patent_doc_number] => 20100040710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'Stimulation of the synthesis and of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers.' [patent_app_type] => utility [patent_app_number] => 12/367299 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16422 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20100040710.pdf [firstpage_image] =>[orig_patent_app_number] => 12367299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8807774 [patent_doc_number] => 08445426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-21 [patent_title] => 'Peptides and methods for producing them' [patent_app_type] => utility [patent_app_number] => 12/364128 [patent_app_country] => US [patent_app_date] => 2009-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12470 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12364128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5502731 [patent_doc_number] => 20090163419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'Human growth hormone aqueous formulation' [patent_app_type] => utility [patent_app_number] => 12/321084 [patent_app_country] => US [patent_app_date] => 2009-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3429 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20090163419.pdf [firstpage_image] =>[orig_patent_app_number] => 12321084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5342407 [patent_doc_number] => 20090181057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'Methods and Compositions for the Inhibition of Thrombus Formation' [patent_app_type] => utility [patent_app_number] => 12/354525 [patent_app_country] => US [patent_app_date] => 2009-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20119 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181057.pdf [firstpage_image] =>[orig_patent_app_number] => 12354525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5386243 [patent_doc_number] => 20090227488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'Class of bioactive glycoprotein' [patent_app_type] => utility [patent_app_number] => 12/314747 [patent_app_country] => US [patent_app_date] => 2008-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 10827 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227488.pdf [firstpage_image] =>[orig_patent_app_number] => 12314747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8772400 [patent_doc_number] => 08426356 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-23 [patent_title] => 'Aminothiazoles and their uses' [patent_app_type] => utility [patent_app_number] => 12/333602 [patent_app_country] => US [patent_app_date] => 2008-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15896 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12333602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 112639 [patent_doc_number] => 07713930 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-11 [patent_title] => 'Acidic insulin preparations having improved stability' [patent_app_type] => utility [patent_app_number] => 12/328208 [patent_app_country] => US [patent_app_date] => 2008-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4332 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/713/07713930.pdf [firstpage_image] =>[orig_patent_app_number] => 12328208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7687326 [patent_doc_number] => 20090176965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Sericin Having Improved Antioxidant and Tyrosinase Inhibitive Abilities by Irradiation, and Methods of Making and Using the Same' [patent_app_type] => utility [patent_app_number] => 12/324162 [patent_app_country] => US [patent_app_date] => 2008-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4532 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176965.pdf [firstpage_image] =>[orig_patent_app_number] => 12324162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5404713 [patent_doc_number] => 20090240028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'Synthesis and Application of New Structural Well Defined Branched Polymers as Conjugating Agents for Peptides' [patent_app_type] => utility [patent_app_number] => 12/276885 [patent_app_country] => US [patent_app_date] => 2008-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 30494 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20090240028.pdf [firstpage_image] =>[orig_patent_app_number] => 12276885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564982 [patent_doc_number] => 20090137835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'PROCESSES FOR INTERMEDIATES FOR MACROCYCLIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/273648 [patent_app_country] => US [patent_app_date] => 2008-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 18326 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137835.pdf [firstpage_image] =>[orig_patent_app_number] => 12273648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5580628 [patent_doc_number] => 20090175974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'NOVEL CADHERIN RECEPTOR PEPTIDE FOR POTENTIATING Bt BIOPESTICIDES' [patent_app_type] => utility [patent_app_number] => 12/272903 [patent_app_country] => US [patent_app_date] => 2008-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8013 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175974.pdf [firstpage_image] =>[orig_patent_app_number] => 12272903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515366 [patent_doc_number] => 20090215673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'PROCESS FOR PURIFYING GLYCOPEPTIDE PHOSPHONATE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/272554 [patent_app_country] => US [patent_app_date] => 2008-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15096 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215673.pdf [firstpage_image] =>[orig_patent_app_number] => 12272554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5279172 [patent_doc_number] => 20090131304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Semi-Synthetic Desmethyl-Vancomycin-Based Glycopeptides With Antibiotic Activity' [patent_app_type] => utility [patent_app_number] => 12/268364 [patent_app_country] => US [patent_app_date] => 2008-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9802 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131304.pdf [firstpage_image] =>[orig_patent_app_number] => 12268364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5527973 [patent_doc_number] => 20090198050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'Macrocyclic Modulators of the Ghrelin Receptor' [patent_app_type] => utility [patent_app_number] => 12/263179 [patent_app_country] => US [patent_app_date] => 2008-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 63800 [patent_no_of_claims] => 118 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20090198050.pdf [firstpage_image] =>[orig_patent_app_number] => 12263179 [rel_patent_id] =>[rel_patent_doc_number] =>)